Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil
· Delayed Price · Currency is BRL 124.80
+3.20 (2.63%)
Last updated: Dec 3, 2025, 5:00 PM GMT-3
61.49% (1Y)
| Market Cap | 325.76B |
| Revenue (ttm) | 17.11B |
| Net Income (ttm) | 232.18M |
| Shares Out | n/a |
| EPS (ttm) | 1.76 |
| PE Ratio | 1,403.07 |
| Forward PE | 43.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 122 |
| Average Volume | 106 |
| Open | 126.48 |
| Previous Close | 121.60 |
| Day's Range | 124.80 - 126.48 |
| 52-Week Range | 67.16 - 132.40 |
| Beta | 0.30 |
| RSI | 56.25 |
| Earnings Date | Nov 6, 2025 |